Zobrazeno 1 - 10
of 290
pro vyhledávání: '"Catalani, O"'
Autor:
Hermans C; Division of Haematology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium., Ventriglia G; Product Development Clinical Science Hematology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Obaji S; Cardiff Haemophilia Centre, University Hospital of Wales, Cardiff, United Kingdom., Beckermann BM; Product Development Clinical Science Oncology & Hematology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Lehle M; Product Development Clinical Science Oncology & Hematology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Catalani O; Statistics, F. Hoffmann-La Roche Ltd, Basel, Switzerland., d'Oiron R; Reference centre for Haemophilia and Rare Congenital Bleeding Disorders, Bicêtre Hospital AP-HP, University of Paris-Saclay and UMR-S1176 INSERM, Le Kremlin-Bicêtre, France., Frenzel L; Centre de Traitement de l'Hémophilie, AP-HP, Hôpital Necker Enfants Malades, Paris, France.
Publikováno v:
Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2023 Oct 21; Vol. 7 (8), pp. 102239. Date of Electronic Publication: 2023 Oct 21 (Print Publication: 2023).
Autor:
Négrier C; Claude Bernard Lyon 1 University, Lyon, France. Electronic address: claude.negrier@univ-lyon1.fr., Mahlangu J; University of the Witwatersrand and NHLS, Johannesburg, South Africa., Lehle M; F Hoffmann-La Roche, Basel, Switzerland., Chowdary P; Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free London, London, UK., Catalani O; F Hoffmann-La Roche, Basel, Switzerland., Bernardi RJ; Genentech, San Francisco, CA, USA., Jiménez-Yuste V; La Paz University Hospital, Autonomous University of Madrid, Madrid, Spain., Beckermann BM; F Hoffmann-La Roche, Basel, Switzerland., Schmitt C; F Hoffmann-La Roche, Basel, Switzerland., Ventriglia G; F Hoffmann-La Roche, Basel, Switzerland., Windyga J; Department of Hemostasis Disorders and Internal Medicine, Laboratory of Hemostasis and Metabolic Diseases, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., d'Oiron R; Bicêtre Hospital AP-HP, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bicêtre, Paris, France., Moorehead P; Memorial University of Newfoundland, St John's, NL, Canada., Koparkar S; Genentech, San Francisco, CA, USA., Teodoro V; F Hoffmann-La Roche, Basel, Switzerland., Shapiro AD; Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, USA., Oldenburg J; Institute of Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany., Hermans C; University Clinic of Saint Luke, Catholic University of Louvain, Brussels, Belgium.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2023 Mar; Vol. 10 (3), pp. e168-e177. Date of Electronic Publication: 2023 Jan 27.
Autor:
Konopleva MY; University of Texas MD Anderson Cancer Center, Houston, TX., Röllig C; Universitätsklinikum Carl Gustav Carus, Dresden, Germany., Cavenagh J; Barts Health National Health Service Trust Hospital, London, United Kingdom., Deeren D; Algemeen Ziekenhuis Delta, Roeselare, Belgium., Girshova L; Almazov Medical Research Centre, St. Petersburg, Russia., Krauter J; Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie, Braunschweig, Germany., Martinelli G; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Istituto Di Ricovero e Cura a Carattere Scientifico, Meldola, Italy;, Montesinos P; Hospital Universitari i Politècnic La Fe, Valencia, Spain., Schäfer JA; Universitätsklinikum Marburg, Zentrum für Innere Medizin, Klinik für Hämatologie, Onkologie und Immunologie, Marburg, Germany., Ottmann O; Cardiff University, Cardiff, United Kingdom., Petrini M; Hematology Unit Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy., Pigneux A; Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux, France., Rambaldi A; University of Milan and Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy., Recher C; Centre Hospitalier Universitaire de Toulouse, Toulouse, France., Rodriguez-Veiga R; Hospital Universitari i Politècnic La Fe, Valencia, Spain., Taussig D; Royal Marsden National Health Service Foundation Trust, Marsden, United Kingdom., Vey N; Institut Paoli-Calmettes, Marseille, France., Yoon SS; Seoul National University Hospital, Seoul, South Korea., Ott M; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Muehlbauer S; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Beckermann BM; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Catalani O; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Genevray M; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Mundt K; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Jamois C; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Fenaux P; Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France; and., Wei AH; The Alfred Hospital and Monash University, Melbourne, Australia.
Publikováno v:
Blood advances [Blood Adv] 2022 Jul 26; Vol. 6 (14), pp. 4147-4156.
Autor:
Okkels, Anna1 (AUTHOR) anna.okkels@dk.ey.com, Yssing, Cecilie1 (AUTHOR), Wolden, Michael Lyng2 (AUTHOR) mlwo@novonordisk.com, Wahid, Mohd Nawi3 (AUTHOR)
Publikováno v:
Health & Quality of Life Outcomes. 11/13/2024, Vol. 22 Issue 1, p1-11. 11p.
Autor:
Schmitt C; Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Adamkewicz JI; Department of Oncology Biomarker Development, Genentech, Inc., South San Francisco, California, United States., Xu J; Department of Clinical Research, Genentech, Inc., South San Francisco, California, United States., Petry C; Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Catalani O; Department of Pharma-Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Young G; Hemostasis and Thrombosis Program, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California, United States., Negrier C; Hematology Department, Louis Pradel Hospital, University Claude Bernard, Lyon, France., Callaghan MU; Division of Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan, United States., Levy GG; Department of Pharma Development, Genentech, Inc., South San Francisco, California, United States.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2021 Mar; Vol. 121 (3), pp. 351-360. Date of Electronic Publication: 2020 Oct 21.
Autor:
von Mackensen S; Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Catalani O; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Asikanius E; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Paz-Priel I; Genentech, Inc, South San Francisco, CA, USA., Lehle M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Trask P; Genentech, Inc, South San Francisco, CA, USA.
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2020 Nov; Vol. 26 (6), pp. 1019-1030. Date of Electronic Publication: 2020 Oct 21.
Autor:
Montesinos P; Departamento de Hematologia, Hospital Universitari i Politècnic La Fe, València, Spain.; CIBERONC, Instituto Carlos III, Madrid, Spain., Beckermann BM; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Catalani O; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Esteve J; Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain., Gamel K; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Konopleva MY; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Martinelli G; Department of Hematology and Sciences Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Monnet A; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Papayannidis C; Department of Experimental, Diagnostic and Specialty Medicine Institute of Hematology & Medical Oncology L & A Seràgnoli, Bologna, Italy., Park A; Hoffmann-La Roche Ltd, Mississauga, ON, Canada., Récher C; Serviced'Hématologie, Institut Universitaire du Cancer Toulouse - Oncopole,Toulouse, France., Rodríguez-Veiga R; Departamento de Hematologia, Hospital Universitari i Politècnic La Fe, València, Spain., Röllig C; Department of Internal Medicine, Universitätsklinikum Carl Gustav Carus, Dresden, Germany., Vey N; Hematology Department, Aix-Marseille University, Institut Paoli-Calmettes, Marseille, France., Wei AH; Department of Haematology, The Alfred Hospital & Monash University, Melbourne, VIC, Australia., Yoon SS; Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea., Fenaux P; Service d'Hématologie Séniors Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris, Université de Paris, Paris, France.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2020 May; Vol. 16 (13), pp. 807-815. Date of Electronic Publication: 2020 Mar 13.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Oldenburg, J., Hermans, C., Negrier, C., Lehle, M., Chowdary, P., Catalani, O., Jiménez-Yuste, V., Schmitt, C., Ventriglia, G., Windyga, J., Kiialainen, A., d'Oiron, R., Moorehead, P., Koparkar, S., Teodoro, V., Shapiro, A. D.
Publikováno v:
Hämostaseologie; 2023 Supplement, Vol. 43, pS31-S32, 2p
Autor:
Ntwasa, Monde1 (AUTHOR) ntwasmm@unisa.ac.za
Publikováno v:
Cells (2073-4409). Jul2024, Vol. 13 Issue 13, p1124. 11p.